Pictet North America Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Pictet North America Advisors's AMGN Position: Q3 2021 in Review
Pictet North America Advisors sold out of Amgen (AMGN) in Q3 2021, closing a stake of 10,141 shares — an estimated $2.47M sold.
Pictet North America Advisors first reported a position in AMGN in Q2 2016 and held it in 21 quarters. The position peaked at $2.47M in Q2 2021. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Pictet North America Advisors reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
- Pictet North America Advisors sold 10,141 Amgen shares in Q3 2021, an estimated $2.47M.
- Pictet North America Advisors first reported a position in Amgen in Q2 2016 and held it in 21 quarters.
- Pictet North America Advisors's Amgen position peaked at $2.47M in Q2 2021.
- 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Pictet North America Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.